What is the latest price of imported original research Mirikizumab in 2025?
Mirikizumab-Omvoh is an injection used to treat adults with ulcerative colitis, a disease that causes swelling and ulcers in the lining of the colon and rectum. Militizumab is a monoclonal antibody drug that reduces the symptoms of ulcerative colitis by inhibiting the activity of certain cells in the body.
Milizumab is provided in the form of a solution and is administered intravenously by a doctor or nurse in the medical office. The injection time is at least30 minutes. Additionally, it is available in a prefilled dosing pen for subcutaneous injection at home. The treatment regimen typically involves the first three doses (weeks 0, 4, and 8) given intravenously in the hospital, followed by subcutaneous maintenance every four weeks.

Patients must strictly follow the instructions on the prescription label when using militizumab, ensure that the injection is in accordance with the doctor's instructions, and avoid overdosing or underdosing. If you choose to self-inject, be sure to carefully read and understand the instructions for use, and if in doubt, consult your doctor or pharmacist. Throughout the course of treatment, patients should communicate regularly with the medical team to ensure the safety and effectiveness of treatment. The use of militizumab provides patients with ulcerative colitis an effective treatment option that can help improve quality of life.
Since the original drug of militizumab has not yet been launched in the country, its price is still unclear. This drug has been on the market for a short time overseas. The common specification is 300mg/15mL per tube. The price of each box may exceed more than 10,000 yuan (the price may fluctuate due to the exchange rate), and the overall cost is relatively high. At the same time, there are no generic versions of militizumab available for sale overseas. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
Reference materials:https://medlineplus.gov/druginfo/meds/a623061.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)